Apoquel is considered safe for most adult dogs when used as directed, and it’s one of the most widely prescribed medications for allergic itch in veterinary medicine. That said, it works by dialing down part of the immune system, which means it carries real trade-offs that are worth understanding before your dog starts (or stays on) the medication.
How Apoquel Works
Apoquel (oclacitinib) belongs to a class of drugs called JAK inhibitors. It selectively targets an enzyme called JAK1, which acts as a relay switch for the chemical signals that trigger itching and inflammation in allergic skin disease. By blocking JAK1, Apoquel interrupts the cascade of immune messengers responsible for the relentless scratching, redness, and skin irritation that come with canine allergies.
The selectivity matters. At standard doses, Apoquel’s concentration in the blood is high enough to suppress the itch-driving signals without broadly shutting down other immune functions that rely on different pathways. It’s roughly 10 times more selective for the itch-related enzyme than for some of the other immune enzymes in the same family. That selectivity is what makes it more targeted than older options like steroids, though it’s not perfectly precise, which is where some of the safety concerns come in.
Common Side Effects
In FDA clinical trials, the most frequently reported side effects were mild and affected a small percentage of dogs. During the first week of treatment, about 2.3% of dogs experienced vomiting, 2.3% had diarrhea, 1.8% showed lethargy, and 1.4% had decreased appetite. In a separate study tracking dogs over the first two weeks, the numbers were slightly higher: 4.6% with diarrhea, 3.9% with vomiting, 2.6% with reduced appetite, and 2.0% with lethargy.
These are low rates overall, and the side effects typically resolve on their own. Most dog owners find that Apoquel is well tolerated, especially compared to the side effects of long-term steroid use (excessive thirst, weight gain, panting, behavioral changes). Still, if your dog seems unusually tired or loses interest in food after starting Apoquel, that’s worth mentioning to your vet even though it’s likely temporary.
Infection and Cancer Risks
This is the part of the safety profile that deserves the most attention. Because Apoquel suppresses part of the immune system, it can make dogs more vulnerable to infections. The FDA label specifically warns that it may increase susceptibility to bacterial, fungal, and parasitic infections, including demodicosis (a type of mange caused by mites that a healthy immune system normally keeps in check). Dogs with serious active infections should not take Apoquel.
The cancer question is more nuanced. Apoquel’s label warns that the drug may “exacerbate neoplastic conditions,” meaning it could allow existing cancers or precancerous cells to grow more aggressively by reducing the immune system’s surveillance role. This doesn’t mean Apoquel causes cancer outright, but it means the immune suppression could theoretically give developing tumors a window to progress. Dogs with a known history of cancer need careful evaluation before starting the drug, and all dogs on Apoquel should be regularly checked for new lumps, bumps, or skin masses.
Over the decade since Apoquel’s approval, these risks have remained relatively uncommon in practice, but they aren’t theoretical. They’re the primary reason vets recommend ongoing monitoring rather than simply refilling the prescription indefinitely without check-ins.
Age and Weight Restrictions
Apoquel is approved only for dogs 12 months of age or older. This isn’t an arbitrary cutoff. In a safety study using young dogs (6 months old), the trial had to be stopped early because dogs receiving higher doses developed bacterial pneumonia and generalized demodectic mange. A puppy’s immune system is still maturing, and suppressing it with a JAK inhibitor during that window created serious problems.
On the weight side, the smallest dogs that can take Apoquel weigh about 6.6 pounds (3 kg). If your dog is younger than a year or is a very small breed hovering near that minimum weight, your vet will likely suggest a different approach to managing allergies.
How Apoquel Compares to Cytopoint
Cytopoint (lokivetmab) is the other major modern option for allergic itch in dogs, and the two are frequently compared. Cytopoint is an injectable antibody that targets a single itch-signaling molecule. Because it works like a precision strike rather than broadly modulating immune pathways, its safety profile is notably cleaner. It has no label warnings about cancer or infections, no age restriction, and no concerns about liver metabolism. The most common adverse events are rare injection-site reactions. It can also be used safely in dogs with cancer, organ dysfunction, or active infections.
Apoquel’s advantages are convenience (it’s a daily pill you give at home rather than a monthly injection at the vet) and the fact that it addresses a broader range of inflammatory signals, which can make it more effective for some dogs whose allergies go beyond pure itch. For dogs with complicated health histories, though, Cytopoint is generally considered the safer choice.
Monitoring While on Apoquel
If your dog is going to take Apoquel long-term, expect your vet to request periodic bloodwork. Many veterinarians run baseline blood tests before starting the medication, then recheck at regular intervals. For any medication used longer than six months, routine lab monitoring is standard practice. The main thing vets are watching for is a drop in white blood cell counts, which would signal that the immune suppression has gone too far and the dog is at heightened risk for infections.
Between vet visits, you play a monitoring role too. Check your dog’s skin regularly for new lumps or masses. Watch for signs of infection: ear infections that keep coming back, skin that stays red or weepy despite treatment, urinary issues, or any unusual coughing or lethargy. Dogs can also develop drug sensitivities over time. A dog that tolerated Apoquel perfectly for months could eventually show signs of a reaction, so staying observant matters even after the initial adjustment period.
Who Should Be Cautious
Apoquel isn’t the right fit for every dog. Dogs under 12 months old, dogs with active serious infections, and dogs with a history of cancer all need extra caution or alternative treatments. Dogs with significant liver problems may also warrant closer monitoring, since the drug is processed through the liver, though clinically significant issues at standard doses are uncommon.
For the majority of adult dogs with allergic dermatitis or atopic dermatitis, Apoquel offers fast, effective relief with a manageable risk profile. The side effects that show up in clinical trials are infrequent, and most dogs do well on the medication for extended periods. The key to using it safely is staying on top of veterinary check-ups, keeping up with recommended bloodwork, and paying attention to subtle changes in your dog’s health over time.